ID PUR2_MOUSE Reviewed; 1010 AA. AC Q64737; Q3TGI3; Q6NS48; DT 01-NOV-1997, integrated into UniProtKB/Swiss-Prot. DT 27-JUL-2011, sequence version 3. DT 27-MAR-2024, entry version 191. DE RecName: Full=Trifunctional purine biosynthetic protein adenosine-3 {ECO:0000250|UniProtKB:P22102}; DE Includes: DE RecName: Full=Phosphoribosylamine--glycine ligase {ECO:0000250|UniProtKB:P22102}; DE EC=6.3.4.13 {ECO:0000250|UniProtKB:P22102}; DE AltName: Full=Glycinamide ribonucleotide synthetase; DE Short=GARS; DE AltName: Full=Phosphoribosylglycinamide synthetase; DE Includes: DE RecName: Full=Phosphoribosylformylglycinamidine cyclo-ligase {ECO:0000250|UniProtKB:P22102}; DE EC=6.3.3.1 {ECO:0000250|UniProtKB:P22102}; DE AltName: Full=AIR synthase; DE Short=AIRS; DE AltName: Full=Phosphoribosyl-aminoimidazole synthetase; DE Includes: DE RecName: Full=Phosphoribosylglycinamide formyltransferase {ECO:0000250|UniProtKB:P22102}; DE EC=2.1.2.2 {ECO:0000250|UniProtKB:P22102}; DE AltName: Full=5'-phosphoribosylglycinamide transformylase; DE AltName: Full=GAR transformylase; DE Short=GART; GN Name=Gart; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS LONG AND SHORT). RC STRAIN=C57BL/6 X CBA; TISSUE=Spleen; RX PubMed=8299947; DOI=10.1016/0378-1119(93)90006-o; RA Kan J.L., Jannatipour M., Taylor S.M., Moran R.G.; RT "Mouse cDNAs encoding a trifunctional protein of de novo purine synthesis RT and a related single-domain glycinamide ribonucleotide synthetase."; RL Gene 137:195-202(1993). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE SPLICING, AND TISSUE RP SPECIFICITY. RX PubMed=7829519; DOI=10.1074/jbc.270.4.1823; RA Kan J.L., Moran R.G.; RT "Analysis of a mouse gene encoding three steps of purine synthesis reveals RT use of an intronic polyadenylation signal without alternative exon usage."; RL J. Biol. Chem. 270:1823-1832(1995). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=C57BL/6J; TISSUE=Kidney, Liver, and Stomach; RX PubMed=16141072; DOI=10.1126/science.1112014; RA Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., RA Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., RA Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J., RA Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R., RA Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T., RA Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A., RA Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., RA Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M., RA Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S., RA Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., RA Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D., RA Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M., RA Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H., RA Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V., RA Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S., RA Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H., RA Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N., RA Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F., RA Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., RA Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., RA Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., RA Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., RA Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S., RA Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K., RA Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R., RA van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H., RA Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M., RA Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C., RA Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S., RA Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K., RA Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M., RA Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C., RA Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A., RA Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.; RT "The transcriptional landscape of the mammalian genome."; RL Science 309:1559-1563(2005). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG). RC STRAIN=C57BL/6J; TISSUE=Eye; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [6] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-440 AND SER-467, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung, RC Pancreas, Spleen, and Testis; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). CC -!- FUNCTION: Trifunctional enzyme that catalyzes three distinct reactions CC as part of the 'de novo' inosine monophosphate biosynthetic pathway. CC {ECO:0000250|UniProtKB:P22102}. CC -!- CATALYTIC ACTIVITY: CC Reaction=5-phospho-beta-D-ribosylamine + ATP + glycine = ADP + H(+) + CC N(1)-(5-phospho-beta-D-ribosyl)glycinamide + phosphate; CC Xref=Rhea:RHEA:17453, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:43474, ChEBI:CHEBI:57305, ChEBI:CHEBI:58681, CC ChEBI:CHEBI:143788, ChEBI:CHEBI:456216; EC=6.3.4.13; CC Evidence={ECO:0000250|UniProtKB:P22102}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:17454; CC Evidence={ECO:0000250|UniProtKB:P22102}; CC -!- CATALYTIC ACTIVITY: CC Reaction=2-formamido-N(1)-(5-O-phospho-beta-D-ribosyl)acetamidine + ATP CC = 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole + ADP + H(+) + CC phosphate; Xref=Rhea:RHEA:23032, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:137981, CC ChEBI:CHEBI:147287, ChEBI:CHEBI:456216; EC=6.3.3.1; CC Evidence={ECO:0000250|UniProtKB:P22102}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:23033; CC Evidence={ECO:0000250|UniProtKB:P22102}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(6R)-10-formyltetrahydrofolate + N(1)-(5-phospho-beta-D- CC ribosyl)glycinamide = (6S)-5,6,7,8-tetrahydrofolate + H(+) + N(2)- CC formyl-N(1)-(5-phospho-beta-D-ribosyl)glycinamide; CC Xref=Rhea:RHEA:15053, ChEBI:CHEBI:15378, ChEBI:CHEBI:57453, CC ChEBI:CHEBI:143788, ChEBI:CHEBI:147286, ChEBI:CHEBI:195366; CC EC=2.1.2.2; Evidence={ECO:0000250|UniProtKB:P22102}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:15054; CC Evidence={ECO:0000250|UniProtKB:P22102}; CC -!- COFACTOR: CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; CC Evidence={ECO:0000250|UniProtKB:P15640, ECO:0000255|PROSITE- CC ProRule:PRU00409}; CC Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000255|PROSITE- CC ProRule:PRU00409}; CC Note=Binds 1 magnesium or manganese ion per subunit. CC {ECO:0000255|PROSITE-ProRule:PRU00409}; CC -!- PATHWAY: Purine metabolism; IMP biosynthesis via de novo pathway; 5- CC amino-1-(5-phospho-D-ribosyl)imidazole from N(2)-formyl-N(1)-(5- CC phospho-D-ribosyl)glycinamide: step 2/2. CC {ECO:0000250|UniProtKB:P22102}. CC -!- PATHWAY: Purine metabolism; IMP biosynthesis via de novo pathway; N(1)- CC (5-phospho-D-ribosyl)glycinamide from 5-phospho-alpha-D-ribose 1- CC diphosphate: step 2/2. {ECO:0000250|UniProtKB:P22102}. CC -!- PATHWAY: Purine metabolism; IMP biosynthesis via de novo pathway; N(2)- CC formyl-N(1)-(5-phospho-D-ribosyl)glycinamide from N(1)-(5-phospho-D- CC ribosyl)glycinamide (10-formyl THF route): step 1/1. CC {ECO:0000250|UniProtKB:P22102}. CC -!- SUBUNIT: Homodimer. {ECO:0000250|UniProtKB:P22102}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=Long; CC IsoId=Q64737-1; Sequence=Displayed; CC Name=Short; CC IsoId=Q64737-2; Sequence=VSP_005518; CC -!- TISSUE SPECIFICITY: Detected in liver, kidney and brain. CC {ECO:0000269|PubMed:7829519}. CC -!- DOMAIN: The N-terminal ATP-grasp domain carries the CC phosphoribosylamine--glycine ligase activity. CC {ECO:0000250|UniProtKB:P22102}. CC -!- DOMAIN: The central AIRS domain carries the CC phosphoribosylformylglycinamidine cyclo-ligase activity. CC {ECO:0000250|UniProtKB:P22102}. CC -!- DOMAIN: The C-terminal GART domain carries the CC phosphoribosylglycinamide formyltransferase activity. CC {ECO:0000250|UniProtKB:P22102}. CC -!- SIMILARITY: In the N-terminal section; belongs to the GARS family. CC {ECO:0000305}. CC -!- SIMILARITY: In the central section; belongs to the AIR synthase family. CC {ECO:0000305}. CC -!- SIMILARITY: In the C-terminal section; belongs to the GART family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; U01023; AAA19012.1; -; mRNA. DR EMBL; U01024; AAA19013.1; -; mRNA. DR EMBL; U20886; AAC53250.1; -; Genomic_DNA. DR EMBL; U20875; AAC53250.1; JOINED; Genomic_DNA. DR EMBL; U20876; AAC53250.1; JOINED; Genomic_DNA. DR EMBL; U20877; AAC53250.1; JOINED; Genomic_DNA. DR EMBL; U20879; AAC53250.1; JOINED; Genomic_DNA. DR EMBL; U20880; AAC53250.1; JOINED; Genomic_DNA. DR EMBL; U20881; AAC53250.1; JOINED; Genomic_DNA. DR EMBL; U20882; AAC53250.1; JOINED; Genomic_DNA. DR EMBL; U20883; AAC53250.1; JOINED; Genomic_DNA. DR EMBL; U20892; AAC53251.1; -; Genomic_DNA. DR EMBL; U20875; AAC53251.1; JOINED; Genomic_DNA. DR EMBL; U20876; AAC53251.1; JOINED; Genomic_DNA. DR EMBL; U20877; AAC53251.1; JOINED; Genomic_DNA. DR EMBL; U20879; AAC53251.1; JOINED; Genomic_DNA. DR EMBL; U20880; AAC53251.1; JOINED; Genomic_DNA. DR EMBL; U20881; AAC53251.1; JOINED; Genomic_DNA. DR EMBL; U20882; AAC53251.1; JOINED; Genomic_DNA. DR EMBL; U20883; AAC53251.1; JOINED; Genomic_DNA. DR EMBL; U20886; AAC53251.1; JOINED; Genomic_DNA. DR EMBL; U20884; AAC53251.1; JOINED; Genomic_DNA. DR EMBL; U20887; AAC53251.1; JOINED; Genomic_DNA. DR EMBL; U20885; AAC53251.1; JOINED; Genomic_DNA. DR EMBL; U20889; AAC53251.1; JOINED; Genomic_DNA. DR EMBL; U20890; AAC53251.1; JOINED; Genomic_DNA. DR EMBL; U20891; AAC53251.1; JOINED; Genomic_DNA. DR EMBL; AK168501; BAE40386.1; -; mRNA. DR EMBL; AK168724; BAE40565.1; -; mRNA. DR EMBL; AK168796; BAE40629.1; -; mRNA. DR EMBL; AK168864; BAE40683.1; -; mRNA. DR EMBL; AK168876; BAE40694.1; -; mRNA. DR EMBL; CH466602; EDL03819.1; -; Genomic_DNA. DR EMBL; BC070465; AAH70465.1; -; mRNA. DR CCDS; CCDS28329.1; -. [Q64737-1] DR PIR; I67805; I67805. DR RefSeq; NP_034386.2; NM_010256.2. [Q64737-1] DR RefSeq; XP_006522973.1; XM_006522910.3. DR RefSeq; XP_006522974.1; XM_006522911.2. DR RefSeq; XP_006522975.1; XM_006522912.1. DR AlphaFoldDB; Q64737; -. DR SMR; Q64737; -. DR BioGRID; 199831; 6. DR STRING; 10090.ENSMUSP00000023684; -. DR BindingDB; Q64737; -. DR ChEMBL; CHEMBL3690; -. DR DrugCentral; Q64737; -. DR GuidetoPHARMACOLOGY; 2612; -. DR GlyGen; Q64737; 1 site, 1 O-linked glycan (1 site). DR iPTMnet; Q64737; -. DR MetOSite; Q64737; -. DR PhosphoSitePlus; Q64737; -. DR SwissPalm; Q64737; -. DR EPD; Q64737; -. DR jPOST; Q64737; -. DR MaxQB; Q64737; -. DR PaxDb; 10090-ENSMUSP00000023684; -. DR PeptideAtlas; Q64737; -. DR ProteomicsDB; 302030; -. [Q64737-1] DR ProteomicsDB; 302031; -. [Q64737-2] DR Pumba; Q64737; -. DR Antibodypedia; 1063; 250 antibodies from 31 providers. DR DNASU; 14450; -. DR Ensembl; ENSMUST00000023684.14; ENSMUSP00000023684.8; ENSMUSG00000022962.16. [Q64737-1] DR Ensembl; ENSMUST00000120450.2; ENSMUSP00000114034.2; ENSMUSG00000022962.16. [Q64737-2] DR Ensembl; ENSMUST00000231380.2; ENSMUSP00000156232.2; ENSMUSG00000022962.16. [Q64737-2] DR Ensembl; ENSMUST00000232289.2; ENSMUSP00000156002.2; ENSMUSG00000022962.16. [Q64737-1] DR GeneID; 14450; -. DR KEGG; mmu:14450; -. DR UCSC; uc007zxu.1; mouse. [Q64737-1] DR AGR; MGI:95654; -. DR CTD; 2618; -. DR MGI; MGI:95654; Gart. DR VEuPathDB; HostDB:ENSMUSG00000022962; -. DR eggNOG; KOG0237; Eukaryota. DR eggNOG; KOG3076; Eukaryota. DR GeneTree; ENSGT00390000000292; -. DR HOGENOM; CLU_005361_0_2_1; -. DR InParanoid; Q64737; -. DR OMA; EVMQACC; -. DR OrthoDB; 729at2759; -. DR PhylomeDB; Q64737; -. DR TreeFam; TF106368; -. DR Reactome; R-MMU-73817; Purine ribonucleoside monophosphate biosynthesis. DR SABIO-RK; Q64737; -. DR UniPathway; UPA00074; UER00125. DR UniPathway; UPA00074; UER00126. DR UniPathway; UPA00074; UER00129. DR BioGRID-ORCS; 14450; 27 hits in 78 CRISPR screens. DR ChiTaRS; Gart; mouse. DR PRO; PR:Q64737; -. DR Proteomes; UP000000589; Chromosome 16. DR RNAct; Q64737; Protein. DR Bgee; ENSMUSG00000022962; Expressed in ileal epithelium and 292 other cell types or tissues. DR ExpressionAtlas; Q64737; baseline and differential. DR GO; GO:0005829; C:cytosol; IDA:MGI. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0004637; F:phosphoribosylamine-glycine ligase activity; IDA:MGI. DR GO; GO:0004641; F:phosphoribosylformylglycinamidine cyclo-ligase activity; ISO:MGI. DR GO; GO:0004644; F:phosphoribosylglycinamide formyltransferase activity; ISO:MGI. DR GO; GO:0044208; P:'de novo' AMP biosynthetic process; IDA:MGI. DR GO; GO:0006189; P:'de novo' IMP biosynthetic process; IDA:MGI. DR GO; GO:0097294; P:'de novo' XMP biosynthetic process; IDA:MGI. DR GO; GO:0046084; P:adenine biosynthetic process; IBA:GO_Central. DR GO; GO:0003360; P:brainstem development; IEA:Ensembl. DR GO; GO:0021549; P:cerebellum development; IEA:Ensembl. DR GO; GO:0021987; P:cerebral cortex development; IEA:Ensembl. DR GO; GO:0006544; P:glycine metabolic process; ISO:MGI. DR GO; GO:0006177; P:GMP biosynthetic process; IDA:MGI. DR GO; GO:0006164; P:purine nucleotide biosynthetic process; IBA:GO_Central. DR GO; GO:0010035; P:response to inorganic substance; ISO:MGI. DR GO; GO:0010033; P:response to organic substance; ISO:MGI. DR GO; GO:0046654; P:tetrahydrofolate biosynthetic process; ISO:MGI. DR CDD; cd08645; FMT_core_GART; 1. DR CDD; cd02196; PurM; 1. DR Gene3D; 3.40.50.20; -; 1. DR Gene3D; 3.30.1490.20; ATP-grasp fold, A domain; 1. DR Gene3D; 3.30.470.20; ATP-grasp fold, B domain; 1. DR Gene3D; 3.40.50.170; Formyl transferase, N-terminal domain; 1. DR Gene3D; 3.90.600.10; Phosphoribosylglycinamide synthetase, C-terminal domain; 1. DR Gene3D; 3.90.650.10; PurM-like C-terminal domain; 1. DR Gene3D; 3.30.1330.10; PurM-like, N-terminal domain; 1. DR HAMAP; MF_00741; AIRS; 1. DR HAMAP; MF_00138; GARS; 1. DR HAMAP; MF_01930; PurN; 1. DR InterPro; IPR011761; ATP-grasp. DR InterPro; IPR013815; ATP_grasp_subdomain_1. DR InterPro; IPR002376; Formyl_transf_N. DR InterPro; IPR036477; Formyl_transf_N_sf. DR InterPro; IPR004607; GART. DR InterPro; IPR001555; GART_AS. DR InterPro; IPR016185; PreATP-grasp_dom_sf. DR InterPro; IPR020561; PRibGlycinamid_synth_ATP-grasp. DR InterPro; IPR000115; PRibGlycinamide_synth. DR InterPro; IPR020560; PRibGlycinamide_synth_C-dom. DR InterPro; IPR037123; PRibGlycinamide_synth_C_sf. DR InterPro; IPR020559; PRibGlycinamide_synth_CS. DR InterPro; IPR020562; PRibGlycinamide_synth_N. DR InterPro; IPR010918; PurM-like_C_dom. DR InterPro; IPR036676; PurM-like_C_sf. DR InterPro; IPR016188; PurM-like_N. DR InterPro; IPR036921; PurM-like_N_sf. DR InterPro; IPR004733; PurM_cligase. DR InterPro; IPR011054; Rudment_hybrid_motif. DR NCBIfam; TIGR00877; purD; 1. DR NCBIfam; TIGR00878; purM; 1. DR NCBIfam; TIGR00639; PurN; 1. DR PANTHER; PTHR10520:SF12; TRIFUNCTIONAL PURINE BIOSYNTHETIC PROTEIN ADENOSINE-3; 1. DR PANTHER; PTHR10520; TRIFUNCTIONAL PURINE BIOSYNTHETIC PROTEIN ADENOSINE-3-RELATED; 1. DR Pfam; PF00586; AIRS; 1. DR Pfam; PF02769; AIRS_C; 1. DR Pfam; PF00551; Formyl_trans_N; 1. DR Pfam; PF01071; GARS_A; 1. DR Pfam; PF02843; GARS_C; 1. DR Pfam; PF02844; GARS_N; 1. DR SMART; SM01209; GARS_A; 1. DR SMART; SM01210; GARS_C; 1. DR SUPFAM; SSF53328; Formyltransferase; 1. DR SUPFAM; SSF56059; Glutathione synthetase ATP-binding domain-like; 1. DR SUPFAM; SSF52440; PreATP-grasp domain; 1. DR SUPFAM; SSF56042; PurM C-terminal domain-like; 1. DR SUPFAM; SSF55326; PurM N-terminal domain-like; 1. DR SUPFAM; SSF51246; Rudiment single hybrid motif; 1. DR PROSITE; PS50975; ATP_GRASP; 1. DR PROSITE; PS00184; GARS; 1. DR PROSITE; PS00373; GART; 1. DR Genevisible; Q64737; MM. PE 1: Evidence at protein level; KW Acetylation; Alternative splicing; ATP-binding; Ligase; Magnesium; KW Manganese; Metal-binding; Multifunctional enzyme; Nucleotide-binding; KW Phosphoprotein; Purine biosynthesis; Reference proteome; Transferase. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0000250|UniProtKB:P22102" FT CHAIN 2..1010 FT /note="Trifunctional purine biosynthetic protein adenosine- FT 3" FT /id="PRO_0000074938" FT DOMAIN 111..318 FT /note="ATP-grasp" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00409" FT REGION 434..809 FT /note="AIRS domain" FT /evidence="ECO:0000250|UniProtKB:P21872" FT REGION 810..1010 FT /note="GART domain" FT /evidence="ECO:0000250|UniProtKB:P22102" FT ACT_SITE 915 FT /note="Proton donor" FT /evidence="ECO:0000250|UniProtKB:P08179" FT BINDING 190..193 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:P22102" FT BINDING 197 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:P22102" FT BINDING 220 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:P22102" FT BINDING 229 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:P22102" FT BINDING 288 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00409" FT BINDING 290 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00409" FT BINDING 818..820 FT /ligand="N(1)-(5-phospho-beta-D-ribosyl)glycinamide" FT /ligand_id="ChEBI:CHEBI:143788" FT /evidence="ECO:0000250|UniProtKB:P22102" FT BINDING 871 FT /ligand="(6R)-10-formyltetrahydrofolate" FT /ligand_id="ChEBI:CHEBI:195366" FT /evidence="ECO:0000250|UniProtKB:P22102" FT BINDING 896..899 FT /ligand="(6R)-10-formyltetrahydrofolate" FT /ligand_id="ChEBI:CHEBI:195366" FT /evidence="ECO:0000250|UniProtKB:P22102" FT BINDING 913 FT /ligand="(6R)-10-formyltetrahydrofolate" FT /ligand_id="ChEBI:CHEBI:195366" FT /evidence="ECO:0000250|UniProtKB:P22102" FT BINDING 947..951 FT /ligand="(6R)-10-formyltetrahydrofolate" FT /ligand_id="ChEBI:CHEBI:195366" FT /evidence="ECO:0000250|UniProtKB:P22102" FT BINDING 977..980 FT /ligand="N(1)-(5-phospho-beta-D-ribosyl)glycinamide" FT /ligand_id="ChEBI:CHEBI:143788" FT /evidence="ECO:0000250|UniProtKB:P22102" FT SITE 951 FT /note="Raises pKa of active site His" FT /evidence="ECO:0000250|UniProtKB:P08179" FT MOD_RES 2 FT /note="N-acetylalanine" FT /evidence="ECO:0000250|UniProtKB:P22102" FT MOD_RES 10 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P22102" FT MOD_RES 350 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:P22102" FT MOD_RES 440 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 467 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 682 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:P22102" FT VAR_SEQ 434..1010 FT /note="Missing (in isoform Short)" FT /evidence="ECO:0000303|PubMed:8299947" FT /id="VSP_005518" FT CONFLICT 41 FT /note="C -> G (in Ref. 1; AAA19012/AAA19013 and 2; FT AAC53250/AAC53251)" FT /evidence="ECO:0000305" FT CONFLICT 318 FT /note="D -> G (in Ref. 2; AAC53250/AAC53251)" FT /evidence="ECO:0000305" FT CONFLICT 563 FT /note="G -> A (in Ref. 1; AAA19013)" FT /evidence="ECO:0000305" FT CONFLICT 690 FT /note="I -> T (in Ref. 1; AAA19013)" FT /evidence="ECO:0000305" FT CONFLICT 868 FT /note="Y -> S (in Ref. 1; AAA19013)" FT /evidence="ECO:0000305" SQ SEQUENCE 1010 AA; 107503 MW; 894D7D07D3C258B2 CRC64; MAARVLVIGS GGREHTLAWK LAQSPQVKQV LVAPGNAGTA CAGKISNAAV SVNDHSALAQ FCKDEKIELV VVGPEAPLAA GIVGDLTSAG VRCFGPTAQA AQLESSKKFA KEFMDRHEIP TAQWRAFTNP EDACSFITSA NFPALVVKAS GLAAGKGVIV AKSQAEACRA VQEIMQEKSF GAAGETVVVE EFLEGEEVSC LCFTDGKTVA EMPPAQDHKR LLDGDEGPNT GGMGAYCPAP QVSKDLLVKI KNTILQRAVD GMQQEGAPYT GILYAGIMLT KDGPKVLEFN CRFGDPECQV ILPLLKSDLY EVMQSTLDGL LSASLPVWLE NHSAVTVVMA SKGYPGAYTK GVEITGFPEA QALGLQVFHA GTALKDGKVV TSGGRVLTVT AVQENLMSAL AEARKGLAAL KFEGAIYRKD IGFRAVAFLQ RPRGLTYKDS GVDIAAGNML VKKIQPLAKA TSRPGCSVDL GGFAGLFDLK AAGFKDPLLA SGTDGVGTKL KIAQLCNKHD SIGQDLVAMC VNDILAQGAE PLFFLDYFSC GKLDLSTTEA VIAGIAAACQ QAGCALLGGE TAEMPNMYPP GEYDLAGFAV GAMERHQKLP QLERITEGDA VIGVASSGLH SNGFSLVRKI VERSSLQYSS PAPGGCGDQT LGDLLLTPTR IYSHSLLPII RSGRVKAFAH ITGGGLLENI PRVLPQKFGV DLDASTWRVP KVFSWLQQEG ELSEEEMART FNCGIGAALV VSKDQAEQVL HDVRRRQEEA WVIGSVVACP EDSPRVRVKN LIETIQTNGS LVANGFLKSN FPVQQKKARV AVLISGTGSN LQALIDSTRD PKSSSHIVLV ISNKAAVAGL DRAERAGIPT RVINHKLYKN RVEFDNAVDH VLEEFSVDIV CLAGFMRILS GPFVRKWDGK MLNIHPSLLP SFKGSNAHEQ VLEAGVTITG CTVHFVAEDV DAGQIILQEA VPVRRGDTVA TLSERVKVAE HKIFPAALQL VASGAVQLRE DGKIHWAKEQ //